Antimetabolites.
Chu
E
E
NCI-Navy Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Johnston
P G
PG
Takimoto
C H
CH
Politi
P M
PM
Grem
J L
JL
Chabner
B A
BA
Allegra
C J
CJ
D000964:Antimetabolites, Antineoplastic / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology; D015195:Drug Design; D004351:Drug Resistance / Q000502:physiology; D005467:Floxuridine / Q000494:pharmacology; D005472:Fluorouracil / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology
D000964:Antimetabolites, Antineoplastic; D011687:Purines; D005467:Floxuridine; D003561:Cytarabine; D005472:Fluorouracil; D008727:Methotrexate